4/15
04:12 pm
amlx
Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch [Yahoo! Finance]
4/9
07:54 pm
amlx
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Medium
Report
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
4/8
09:00 am
amlx
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Low
Report
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
3/31
07:40 am
amlx
Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals (AMLX) Winds Up Avexitide Phase 3 Lucidity Trial Enrollment [Yahoo! Finance]
3/28
07:42 pm
amlx
Is LUCIDITY Trial Completion in Post-Bariatric Hypoglycemia Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
Medium
Report
Is LUCIDITY Trial Completion in Post-Bariatric Hypoglycemia Altering The Investment Case For Amylyx Pharmaceuticals (AMLX)? [Yahoo! Finance]
3/25
08:03 am
amlx
Amylyx Pharmaceuticals (AMLX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $34.00 price target on the stock.
Low
Report
Amylyx Pharmaceuticals (AMLX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $34.00 price target on the stock.
3/24
07:00 am
amlx
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
Low
Report
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
3/19
10:21 am
amlx
Amylyx Pharmaceuticals (AMLX) had its price target raised by Guggenheim from $25.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (AMLX) had its price target raised by Guggenheim from $25.00 to $30.00. They now have a "buy" rating on the stock.
3/10
10:01 pm
amlx
Amylyx Pharmaceuticals Highlights Avexitide LUCIDITY Phase 3 Enrollment, Q3 Data Timing at Leerink Conf. [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals Highlights Avexitide LUCIDITY Phase 3 Enrollment, Q3 Data Timing at Leerink Conf. [Yahoo! Finance]
3/7
02:59 am
amlx
Medium
Report
3/4
08:33 pm
amlx
Amylyx Pharmaceuticals Inc (AMLX) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Inc (AMLX) Q4 2025 Earnings Call Highlights: Strategic Advances and ... [Yahoo! Finance]
3/4
11:30 am
amlx
Amylyx Pharmaceuticals (AMLX) had its price target raised by HC Wainwright from $28.00 to $34.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (AMLX) had its price target raised by HC Wainwright from $28.00 to $34.00. They now have a "buy" rating on the stock.
3/4
04:13 am
amlx
Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout [Yahoo! Finance]
3/4
12:34 am
amlx
Amylyx Refocuses On Avexatide As LUCIDITY Milestone Raises Stakes [Yahoo! Finance]
Medium
Report
Amylyx Refocuses On Avexatide As LUCIDITY Milestone Raises Stakes [Yahoo! Finance]
3/3
12:44 pm
amlx
Amylyx Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Amylyx Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
3/3
11:42 am
amlx
Amylyx Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Neutral
Report
Amylyx Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
3/3
10:08 am
amlx
Amylyx (AMLX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Amylyx (AMLX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
3/3
08:03 am
amlx
Amylyx Pharmaceuticals (AMLX) is now covered by Stifel Nicolaus. They set a "buy" rating and a $21.00 price target on the stock.
Medium
Report
Amylyx Pharmaceuticals (AMLX) is now covered by Stifel Nicolaus. They set a "buy" rating and a $21.00 price target on the stock.
3/3
07:00 am
amlx
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
2/26
09:37 am
amlx
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
2/26
09:00 am
amlx
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
Medium
Report
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
2/24
09:00 am
amlx
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Medium
Report
Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
2/20
08:03 am
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at Bank of America Corporation from $15.00 to $19.00. They now have a "buy" rating on the stock.
High
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at Bank of America Corporation from $15.00 to $19.00. They now have a "buy" rating on the stock.
2/10
08:05 am
amlx
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $20.00 to $28.00. They now have a "buy" rating on the stock.
Low
Report
Amylyx Pharmaceuticals (NASDAQ:AMLX) had its price target raised by analysts at HC Wainwright from $20.00 to $28.00. They now have a "buy" rating on the stock.
2/1
12:22 am
amlx
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million [Yahoo! Finance]
Medium
Report
Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million [Yahoo! Finance]